| 摘要 |
1280393 1 - (3 - Sulphamoyl - 4 - chlorobenzamido) - 3 - (2 - furyl) - pyrrolidine SCIENCE UNION ET CIE SOC FRANCAISE DE RECHERCHE MEDICALE 19 April 1971 [10 March 1970] 11430/70 Heading C2C The novel title compound (I) is made by interacting 3 - sulphamoyl - 4 - chloro - benzoyl chloride and 1-amino-3-(2-furyl)-pyrrolidine. Pharmaceutical preparations suitable in the treatment of oedema or ascites in cardiac, renal or hepatic insufficiency, of hypertension and obesity contain I as active ingredient; administration may be orally, rectally or parenterally.
|
